InsidersTradesSigma
Across 3 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Discover the full record of transactions filed by GOWEN MAXINE, Director. Director active across 2 companies, notably Aclaris Therapeutics, Inc.. Aggregated, 5 reports have been recorded. Breakdown: 0 buy · 1 sell. Total volume traded: €24. Activity tracked since 10 August 2023. The latest transaction was disclosed on 10 August 2023 (Cession). Regulator: SEC (Form 4). All data is openly available.
5 of 5 declarations
Maxine Gowen is a Board Member at Aclaris Therapeutics, Inc., a biopharmaceutical company focused on developing dermatological treatments. As a board member, she participates in overseeing the company's strategies and making key decisions. Maxine has extensive experience in the biopharmaceutical sector, providing valuable insights to the board.